Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee

FHS
July 31, 2024
11:50 am

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the launch of its fourth generation CHO Edge System.

FDA offers more guidance on relying on just one trial and confirmatory evidence for a new drug approval

Although FDA isn’t changing what it requires for a new drug to win approval (that hasn’t changed since 1998), the agency on Monday released new

September 19, 2023

NHS to provide Pfizer’s Voxelotor to treat sickle cell disease

Sickle cell disease is caused by a genetic mutation that results in red blood cells becoming sickle-shaped, leading to haemolytic anaemia. Credit: Victor Josan /

May 3, 2024

Roivant discontinues lung disease drug; Bio-Thera, Intas make biosimilar deal

Plus, news about Caliway Biopharmaceuticals, Orca Bio, Alterity Therapeutics and Ascentage Pharma: Roivant discontinues rare lung disease drug: The termination, disclosed in Roivant’s Sign up

February 11, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.